Interferon alpha-inducible protein 6 (IFI6), also known as G1P3 has been shown to contribute to hyperplasia, tamoxifen resistance and poor outcomes in breast cancer (Cheriyath et al., 2012). This evidence concerns the gene IFI6 and breast carcinoma.